Cardiovascular protection and blood pressure
Multiple RCTs show pomegranate juice and extract significantly reduce systolic blood pressure (by 5–12 mmHg), reduce LDL oxidation, improve endothelial function, and slow carotid intima-media thickness progression — a direct measure of atherosclerosis. One year of pomegranate juice consumption reduced carotid IMT by 30% in a high-risk study.
Exercise recovery and muscle protection
Pomegranate extract significantly reduces post-exercise muscle soreness, strength loss, and oxidative damage markers. Studies in strength athletes show faster recovery, reduced CK and myoglobin elevation, and improved performance in subsequent training sessions.
Prostate health
Pomegranate juice and extract have demonstrated significant effects on PSA doubling time in prostate cancer patients post-treatment — extending the time for PSA levels to double from 15 to 54 months in a UCLA clinical trial. Punicalagins inhibit androgen signaling and promote prostate cancer cell apoptosis.
Memory and cognitive function
A University of California RCT in middle-aged adults showed 8 oz/day pomegranate juice significantly improved verbal and visual memory after 4 weeks, with fMRI confirmation of increased brain activation in memory regions. Urolithin A (gut metabolite) protects neurons via mitophagy induction.
Anti-inflammatory and antioxidant
Pomegranate has among the highest antioxidant capacity of any food (3x red wine, 4x green tea by ORAC). Punicalagins are converted to urolithins by gut microbiota — urolithin A activates mitophagy (cellular mitochondrial quality control), reducing cellular aging and inflammation.
Urolithin A mitophagy activation
Intestinal bacteria convert punicalagins and ellagic acid to urolithins (urolithin A, B, C). Urolithin A activates mitophagy — the selective autophagy of damaged mitochondria — via PINK1/Parkin pathway. This cellular housekeeping mechanism improves mitochondrial quality and reduces inflammasome activation, contributing to anti-aging and anti-inflammatory effects.
NF-κB and inflammatory pathway inhibition
Pomegranate polyphenols inhibit NF-κB nuclear translocation, reducing transcription of inflammatory cytokines (TNF-α, IL-6, IL-1β), COX-2, and adhesion molecules (ICAM-1, VCAM-1). This systemic anti-inflammatory action underlies cardiovascular, joint, and exercise recovery benefits.
Aromatase and androgen receptor inhibition
Pomegranate phytoestrogens and ellagitannins inhibit aromatase (estrogen synthesis) and reduce androgen receptor transcriptional activity. This hormonal mechanism contributes to prostate cancer cell growth inhibition and may influence body composition in men.
RCT of pomegranate juice (50 mL/day = ~1.5 oz of concentrated juice) vs. placebo in 19 hypertensive patients for 1 year.
19 adults with hypertension and carotid artery atherosclerosis. 1-year intervention.
Pomegranate juice group showed 30% reduction in carotid IMT (measure of atherosclerotic progression) vs. 9% increase in placebo group. Blood pressure reduced 12%. LDL oxidation reduced 90%. Landmark cardiovascular trial.
RCT of pomegranate extract (1,000 mg/day Pomella®) vs. placebo in 16 resistance-trained men for 8 days surrounding an eccentric exercise protocol.
16 trained men. Eccentric exercise protocol with pomegranate supplementation.
Pomegranate extract significantly reduced muscle soreness, strength loss recovery time, and inflammatory markers (CK, myoglobin) vs. placebo. Antioxidant capacity increased. Supports use for strength athlete recovery.
Phase 2 clinical trial of pomegranate juice (8 oz/day) in 46 men with rising PSA following prostate cancer surgery or radiotherapy.
46 men post-prostate cancer treatment with rising PSA. 2-year follow-up.
Median PSA doubling time extended from 15 months at baseline to 54 months with pomegranate consumption. 35% of patients showed stable or declining PSA levels. In vitro data confirmed anti-proliferative effects on prostate cancer cells.